Skip Navigation

European Heart Journal 2002 23(20):1633-1634; doi:10.1053/euhj.2002.3342
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cannon, C.P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cannon, C.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters To The Editor

A reply

C.P. Cannon

The TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Havard Medical School, Boston, Massachusetts, U.S.A.

References

  1. Michalis LK, Papamichail N, Katsouras CS. Enoxaparin versus tinzaparin in the management of unstable coronary artery disease (EVET Study) (Abstr). J Am Coll Cardiol. 2001;37:365A
  2. Antman EM, Cohen M, Radley D. Assessment of the treatment effect of enoxaparin for unstable Angina/Non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis. Circulation. 1999;100:1602–1608[Abstract/Free Full Text]
  3. Lancet. 2001;358:605–613[CrossRef][Web of Science][Medline]
  4. Baird SH, Menown IBA, McBride SJ, Trouton TG, Wilson C. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J. 2002;23:627–632[Abstract/Free Full Text]
  5. Antman EM, Louwerenburg HW, Baars HF. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation. 2002;105:1642–1649[Abstract/Free Full Text]
  6. Goodman, S, INTERACT trial, American College of Cardiology Scientific Sessions, Atlanta, 2002
  7. Klein W, Buchwald A, Hillis SE. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in Unstable Coronary Artery Disease Study (FRIC). Circulation. 1997;96:61–68[Abstract/Free Full Text]
  8. Eur Heart J. 1999;20:1553–1562[Abstract/Free Full Text]
  9. Antman EM, McCabe CH, Gurfinkel EP. Enoxaparin prevents death and cardiac ischemic events in unstable Angina/Non-Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial. Circulation. 1999;100:1593–1601[Abstract/Free Full Text]
  10. Holdright D, Patel D, Cunningham D. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol. 1994;24:39–45[Abstract]
  11. Theroux P, Waters D, Qiu S, McCans J, de Guise P, Juneau M. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation. 1993;88:2045–2048[Abstract/Free Full Text]
  12. Newby K, Harrington RA, Bhapkar M, Granger CB, Rames A, Moliterno DJ. Tight control of aPTT in acute coronary syndrome patients using an automated strategy for bedside heparin adjustment: results from the PARAGON A trial. Circulation. 1997;96:I-748
  13. Bozovich GE, Gurfinkel EP, Antman EM, McCabe CH, Mautner B. Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time. Am Heart J. 2000;140:637–642[CrossRef][Web of Science][Medline]
  14. Braunwald, E, Antman, EM, Beasley, JW, ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Unstable Angina), www.acc.org, 2002

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cannon, C.P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cannon, C.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?